VISTIN PHARMA ASA: årsregnskap 2020 vs 2019
Weaker earnings, fresh owner capital
approved 2021-04-22; registry 2021-10-13; journal 2021 810775
Summary
What changed
Comparing Årsregnskap 2020 with 2019 for VISTIN PHARMA ASA. Revenue 0 NOK → 253.9k NOK. Net result +3.13m NOK → +214.0k NOK. Equity 338.8k NOK → 294.71m NOK.
On the constructive side: revenue rose; operating result improved; equity strengthened. Pressures included: net result weakened.
Also worth watching: payroll increased; cogs fell; book investments changed. All figures are taken from the published annual accounts for VISTIN PHARMA ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 0 NOK to 253.9k NOK. Calculated
-
↑
Operating result improved
Operating result -3.02m NOK → -2.82m NOK. Calculated
-
↑
Equity strengthened
Book equity 338.8k NOK → 294.71m NOK (equity ratio 95.5% → 99.7%). Calculated
-
↑
Cash rose
Bank deposits 180.2k NOK → 67.74m NOK (+37485.0% YoY). Calculated
-
↑
Current ratio back above 1×
Current ratio 0.01× → 201.47×. Calculated
What deteriorated
-
↓
Net result weakened
Net result +3.13m NOK → +214.0k NOK. Calculated
Things to notice
-
·
Payroll increased
Salary cost 1.64m NOK → 1.74m NOK. Calculated
-
·
COGS fell
COGS / varekostnad 84.11m NOK → 73.29m NOK (-12.9% YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 127.93m NOK → 106.87m NOK. Reported fact